Encysive’s Thelin Gets EU Nod Ahead Of U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
EU marketing authorization of the pulmonary arterial hypertension treatment follows Encysive’s receipt of a second “approvable” letter for sitaxentan sodium from FDA.